Bio-Techne
TECH
#1989
Rank
C$13.27 B
Marketcap
C$85.21
Share price
-2.93%
Change (1 day)
-17.40%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): C$0.72

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is C$0.69. In 2024 the company made an earnings per share (EPS) of C$1.38 a decrease over its 2023 EPS that were of C$1.96.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.72-48.2%
2024C$1.38-29.58%
2023C$1.96-14.97%
2022C$2.3124.16%
2021C$1.8617.98%
2020C$1.57-10.94%
2019C$1.77101.57%
2018C$0.88-16.99%
2017C$1.0645.02%
2016C$0.73-20.97%
2015C$0.92-14.97%
2014C$1.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$23.96 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C-$33.58-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$7.69 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$6.74 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.58 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
C$10.44 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C-$0.29-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA